Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBALT: Combined Behavioral and Drug Treatment for OAB in Men
NCT01175382Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2010
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolterodine, tamsulosin in overactive bladder (OAB), sponsored by University of Alabama at Birmingham. Started Jul 2010; status: completed.
02
Drugs
tolterodinetamsulosin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01175382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175382.